Episode 35 - Nikkhil Masurkar and How American Healthcare and Indian Pharma Are Connected

My guest in this episode is Nikkhil Masurkar. 

Nikkhil is the CEO of Entod Pharmaceuticals which is based in India. He is often called India’s Eye Drops Man because Entod specializes in ophthalmic, ENT, and dermatological medicines. 

In this interview, Nikkil and I talked about how closely American and Indian pharma worlds are intertwined - 4 out of 10 prescriptions filled in the U.S. are supplied by Indian companies. They supply almost half of all generic prescriptions. This translates to a significant cost savings for the U.S. healthcare system - over $1.3 trillion in last 10 years alone. 

We also talked about  - Why India is considered the 'Pharmacy of the World'  - How Indian pharma companies can move beyond generics into high-value innovation - ⁠How Indian pharma can be a $450 billion industry by 2047 - How to balance affordability with innovation to ensure life-saving drugs reach more people - The biggest regulatory hurdles Indian pharma companies face when expanding in the USA   And what all of it means for the American healthcare system, American pharma industry, and American patients.

We also discussed important leadership lessons, one thing about the Indian pharma industry Nikkhil would change if he could, and what he reads, instead of books, that drives his personal outlook and Entod Pharmaceutical's culture.

I enjoyed my discussion with Nikkhil about how closely American and Indian pharma industries are connected. I hope you do too.

Here's Nikkil Masurkar.